Cytel Inc.

Shaping the future of drug development with software solutions, innovative consulting and proven clinical research services.

[Cytel Inc. @cytel]

Curious to know more about how R Shiny can strengthen evidence communication across the HTA process? Join us for an Office Hours session on how to utilize R Shiny to enhance payer engagement, internal alignment, and post-submission value communication: https://t.co/6dEOHZenvc

[Cytel Inc. @cytel]

Clinical Operations teams are being asked to let go of traditional approaches & do more than ever before. We discuss how to meet these challenges with methods & tools that allow you to spend less time managing the process & more time managing the study. https://t.co/djtnYkEY0f

[Cytel Inc. @cytel]

ISPOR Philadelphia showed an industry moving rapidly from AI experimentation toward AI-enabled infrastructure. Manuel Cossio and Dalia Dawoud share some of their key takeaways and insights on the rise of AI and what will define the next phase of HEOR. https://t.co/BCJKhMbhXw

[Cytel Inc. @cytel]

Curious to know more about how R Shiny can strengthen evidence communication across the HTA process? Join us for an Office Hours session on how to utilize R Shiny to enhance payer engagement, internal alignment, and post-submission value communication: https://t.co/b5VMm30Oki

[Cytel Inc. @cytel]

In clinical development, the demand for faster, more accurate, and scalable solutions around patient data is increasing rapidly. We discuss how AI and automation are reshaping statistical programming, and how to adopt these tools responsibly. https://t.co/9DvyR9gkk4

[Cytel Inc. @cytel]

Organizations are moving beyond static submissions toward more dynamic & continuously updated evidence packages. As agencies explore the role of AI, adoption brings important questions. We will explore how AI is reshaping HTA, offering practical insights: https://t.co/grs29GsCOr

[Cytel Inc. @cytel]

Curious to know more about how R Shiny can strengthen evidence communication across the HTA process? Join us for an Office Hours session on how to utilize R Shiny to enhance payer engagement, internal alignment, and post-submission value communication: https://t.co/0Mcxi9j9VN

[Cytel Inc. @cytel]

Even the strongest trial designs can face challenges once execution begins. Join us for an informal Office Hours session, where you can bring your questions directly to our experts across trial design and execution: https://t.co/mfPu2lWr69

[Cytel Inc. @cytel]

Database Lock is a critical milestone in the clinical trial lifecycle. A final step of clinical data management, DBL can sometimes require accelerated timelines. Veronica Chan discusses how to achieve DBL on time and without sacrificing data quality: https://t.co/XpQpZY3uGq

[Cytel Inc. @cytel]

Cytel will be at ISPOR US in Philadelphia!

📍 Visit us at booth #1039 to speak with our experts in HEOR, Market Access, and RWE and learn more about our innovative offerings.

We hope to see you there!

Book a meeting: https://t.co/qrR5kQUccP

[Cytel Inc. @cytel]

Researchers are exploring ways to generate “synthetic” patient cohorts that behave like real ones. Manuel Cossio and Deepa Jahagirdar discuss a pilot study that explores how LLMs can play a meaningful role in this transformation: https://t.co/BDtCZ63YlJ

[Cytel Inc. @cytel]

Cytel will be at the CDISC + TMF EU Interchange in Milan! Angelo Tinazzi shares a preview of upcoming presentations on Cytel’s work with CDISC standards, including datasets JSON and CORE. https://t.co/1T7FsBZGBl
We hope to see you there!

[Cytel Inc. @cytel]

DMCs discussions, held in closed session, are often complex & nuanced. In our panel discussion, experienced DMC members will offer insight into the judgment, trade-offs & discussions that shape critical trial decisions, with opportunities for live Q&A.
https://t.co/PjamROGmti

[Cytel Inc. @cytel]

Cytel will be at SCOPE X in Boston!

Stop by Booth 24 to meet our experts Michelle Hoiseth, Shariq Alavi, Walter Boyle, Laurent Spiess, and Heather Kowalski, and learn more about our innovative offerings.

Book a meeting: https://t.co/UEZAZ7vu68

We hope to see you there!

[Cytel Inc. @cytel]

Even the strongest trial designs can face challenges once execution begins. Join us for an informal Office Hours session, where you can bring your questions directly to our experts across trial design and execution: https://t.co/J0IDaOTzxr

[Cytel Inc. @cytel]

For organizations leveraging R in regulated environments, a rigorous approach to validation is crucial. We discuss risk.assessr, an open-source tool that allows users to create a practical, data-driven process to meet regulatory requirements. https://t.co/DRJtuY2UXC

[Cytel Inc. @cytel]

HTA landscaping is still a largely manual and time-consuming process that is difficult to scale. Manuel Cossio and Lilia Leisle discuss how agentic AI offers a new way to approach this problem: https://t.co/qteSC9sgZo

[Cytel Inc. @cytel]

DMCs discussions, held in closed session, are often complex & nuanced. In our panel discussion, experienced DMC members will offer insight into the judgment, trade-offs & discussions that shape critical trial decisions, with opportunities for live Q&A.
https://t.co/LkJXFHZ4Ks

[Cytel Inc. @cytel]

Cytel will be at ISPOR US in Philadelphia!

📍 Visit us at booth #1039 to speak with our experts in HEOR, Market Access, and RWE and learn more about our innovative offerings.

We hope to see you there!

Book a meeting: https://t.co/NzQByHd1Gy

[Cytel Inc. @cytel]

Cytel will be at the 2026 CDISC Europe Interchange in Milan!

📍 Stop by Booth #1 to speak with our experts!

👏 Congrats to our presenters: Angelo Tinazzi, Silvia Faini, and Mark Malayas!

We hope to see you in Milan!